Pioneering the detection of early cancer.  Harnessing AI and the biology of cancer's origin.

Harbinger Health

When they're not cranking out the data to support our quest to put the fear of cancer to rest, our data science team (with an assist from our Head of Automation) is out running all the miles! Congratulations to our Harbies who completed the Cambridge Half Marathon recently - Kyle Gowen, Jocelyn Charlton, Jackson Killian, Kade Pettie, Kristy Schlueter-Kuck, and Olga Seltser. We're proud of all that you accomplish both in and out of the office!

#HarbingerHealth #CancerInnovation #MCED #Harbies 

The leaves may be falling outside, but we're not heading for hibernation here at Harbinger - we keep growing! Welcome to our October new hires Ioannis Ladas, Romina Lenci, Charles 'Riggs' Raymond, CPA, Helen Oyinlola, Tracy W., Hawra Al-Rekabi, and Mattie Toolin. We're excited to see all that you achieve here!

Harbinger Health is proud to introduce our Belonging Initiative, which places a strong emphasis on ensuring that every member of our team feels a deep sense of belonging from the moment they join us. We consider belonging to be a fundamental and an ongoing aspect of our company culture. Moreover, we extend this sense of belonging to the accessibility of our products for our patients regardless of socio-economic status.  
 
To underscore our commitment to fostering a culture of belonging, our CEO Steve Hahn has signed the MassBio CEO Pledge, demonstrating our dedication to a more equitable and inclusive life sciences industry. Harbinger Health is excited to collaborate with MassBio and other national partners to actively listen and integrate practical initiatives that advance the cause of belonging. 

#belonging #diversityequtyinclusion #accessibilityinhealthcare #MCED #earlycancerdetection


We had a busy September! Welcome to Apple (Supawadee) Chawanthayatham, Dee Williams, Fangyan Yu, Christine Emery, Elena Goldthwait, Jennifer Zarutskie, Mehul G., and Erik Clement - we are so excited to have you on board.

🎤 "We are tackling three challenges in early screening. The first being, do the tests actually detect early stage cancer? The second big issue is clinical informativeness. We need to be able to give answers to a doctor to adequately take care of a patient. And the third issue is access. So many fell behind during Covid; we need to do a better job on cost and decentralization of care."

Our CEO Steve Hahn shared the stage today at #HLTH2023 for an important conversation on the key obstacles in early cancer detection. 

CrUX Dataset

CrUX Top 50m

Chief Operating Officer

Rob Carson

CEO at Harbinger Health, CEO-Partner at Flagship Pioneering

Steve Hahn

VP, Head of Finance

Anli Serfontein

SVP, Portfolio Strategy and Operations

David Lambe

VP, Digital Systems

David Sexton

VP, Assay Development and Innovation

Rosemary Witkowski

Vice President, Head of Translational Assay Operations and Clinical Lab

Thomas Mullen

Associate Director, Talent Acquisition

Conor Sullivan

Senior Technical Director, Laboratory Operations

Daniel Sisco

Head, Clinical Research Science

Johanna Withers

Mark P. Stevenson

Dymeka Harrison

Chief Commercial Officer

Mathew Sargent

Chief Business Officer

Anthony P. Shuber

Chief Innovation Officer

Gisela A. Paulsen

Companies With Less Than $500M in Revenue (Top 10K)

Health Care Companies With Fewer Than 1000 Employees (Top 10K)

Northeastern US Companies With More Than 10 Employees (Top 10K)

Companies With More Than $1M in Revenue (Top 10K)

Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test. The company combines artificial intelligence with insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing low-cost, multi-cancer blood tests.

Flagship Pioneering

Series B - Harbinger Health

Series A - Harbinger Health

Cambridge

Massachusetts

United States

North America

Harbinger Health Announces Data Showcasing Product Innovations of Its Blood-based Platform for Early Cancer Detection

Harbinger Health Presents Data Demonstrating Novel Capabilities of its Computational Platform to Enhance Performance and Clinical Informativeness in Blood-based Early Cancer Detection

Harbinger Health Announces New Partnership with Leading Cancer Center to Accelerate Clinical Evidence Generation

Harbinger Health on LinkedIn: Colorectal cancer is our hidden nemesis, often showing no symptoms until…

Health Tech: Tale of two med techs

Follow the Money: Generative AI, bioMérieux Expands Oxford ...

Former FDA commissioner Stephen Hahn now leads Flagship ...

A blood-based cancer screening platform designed to detect early-stage cancer across multiple types.

A clinical study in collaboration with the Sarah Cannon Research Institute to validate the diagnostic accuracy of HarbingerHx for early-stage cancer detection.

A proprietary testing model aimed at making cancer screening accessible globally, improving predictive value and enabling individual monitoring.

India

Asia

Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis, and management. They combine advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic. Their aim is to develop a low-cost, multi-cancer blood test.

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	37684193
crunchbase profile	general	Nov 22, 2024 9:06 AM	6b63d35b
li profile	general	Dec 1, 2023 12:22 AM	c88e80dd
translate crunchbase fundingrounds	general	Nov 22, 2024 1:51 PM	529c668b
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:HARBINGER-HEALTH

Harbinger Health